REQUEST A DEMO
Total
USD $0.00
Search more companies

Cong Ty Co Phan Duoc Pham Cuu Long (Vietnam)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Cong Ty Co Phan Duoc Pham Cuu Long Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Cuu Long Pharmaceutical JSC (DCL) is a well-established company in the pharmaceutical industry in Vietnam. With over 46 years of experience, DCL has gained a strong reputation among consumers, pharmacies, and major hospitals. DCL focuses on supplying specialized and basic therapeutic drugs, empty hard capsules, and medical devices. The company currently operates four factories equipped with advanced technology from Canada and South Korea. These include two pharmaceutical factories with pharmaceutical farms, one medical equipment factory, and one capsule factory. Vicancap, the capsule factory, is the only one in Vietnam that produces and supplies all types of capsules. DCL is committed to improving the quality of its capsule production to expand its market share. The company is currently constructing four new capsule factories to increase its capacity by 2 billion capsules per year, which will be operational by 2023. DCL's main product line is medicine production, with over 250 approved therapeutic drugs. They also produce medical equipment and a variety of capsules for pharmaceutical and functional food purposes. DCL has an extensive distribution network covering all of Vietnam and is a trusted pharmaceutical supplier for major hospitals. The company has 13 branches and over 55 distributors. Since QI/2015, DCL has been a member of FIT Group and has received investments in capital and human resources. DCL is focused on improving its management activities, operations, manufacturing, and sales to develop its business and better control its debt. The company is also expanding and upgrading its factories to increase capacity. With the support of FIT Group, DCL aims to become one of the top pharmaceutical companies in Vietnam. They are dedicated to researching new products using modern systems and professional human resources. In addition to their business activities, DCL actively participates in social initiatives, focusing on health, environmental protection, and employee well-being. They strive to build a corporate culture that aligns with their core values.

Headquarters
No. 150 Str. 14/9, Ward 5
Vinh Long; Mekong River Delta; Postal Code: 89

Contact Details: Purchase the Cong Ty Co Phan Duoc Pham Cuu Long report to view the information.

Website: http://www.pharimexco.com.vn

Basic Information
Total Employees:
Purchase the Cong Ty Co Phan Duoc Pham Cuu Long report to view the information.
Outstanding Shares:
Purchase the Cong Ty Co Phan Duoc Pham Cuu Long report to view the information.
Registered Capital:
Purchase the Cong Ty Co Phan Duoc Pham Cuu Long report to view the information.
Financial Auditors:
Purchase the Cong Ty Co Phan Duoc Pham Cuu Long report to view the information.
Incorporation Date:
September 17, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Ownership Details
Purchase this report to view the information.
58.05%
Subsidiaries
Cong Ty Lien Doanh San Xuat Kinh Doanh, Xuat Nhap Khau Duoc Pham Va Thiet Bi Y Te (Msc)
51%
Company Performance
Financial values in the chart are available after Cong Ty Co Phan Duoc Pham Cuu Long report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
12.63%
Total operating revenue
12.63%
Operating profit (EBIT)
-44.16%
EBITDA
-57.49%
Net Profit (Loss) for the Period
-44.96%
Total assets
8.18%
Total equity
4.25%
Operating Profit Margin (ROS)
-6.37%
Net Profit Margin
-5.69%
Return on Equity (ROE)
-3.83%
Debt to Equity Ratio
6.56%
Quick Ratio
-0.32%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?